Key facts
- Notable investors include Phase Two Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Morphos Bioscience
- ·The full record, as it builds
Funding rounds
No funding rounds for Morphos Bioscience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Morphos Bioscience
Developer of a spatial biology platform intended to map tissues using standard sequencing. The company is currently operating in Stealth Mode.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2025
- Website
- morphos.bio/
- Ownership
- Privately Held (backing)
Morphos Bioscience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Morphos Bioscience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Morphos Bioscience in its N-PORT filings yet. We sweep new filings monthly.